AORT - ARTIVION, INC.

37.16
0.130   0.350%

Share volume: 225,102
Last Updated: 04-23-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.01%

PREVIOUS CLOSE
CHG
CHG%
$37.03
0.13
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
44%
Profitability 48%
Dept financing 42%
Liquidity 54%
Performance 40%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-4.23%
1 Month
4.09%
3 Months
-13.64%
6 Months
-14.38%
1 Year
55.81%
2 Year
77.63%
Key data
Stock price
$37.16
P/E Ratio 
221.21
DAY RANGE
$36.66 - $37.66
EPS 
$0.22
52 WEEK RANGE
$23.04 - $48.25
52 WEEK CHANGE
$55.87
MARKET CAP 
2.161 B
YIELD 
N/A
SHARES OUTSTANDING 
47.884 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-05-2025
BETA 
0.94
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$306,908
AVERAGE 30 VOLUME 
$440,561
Company detail
CEO: James P. Mackin
Region: US
Website: artivion.com
Employees: 1,300
IPO year: 2006
Issue type: Common Stock
Market: NYSE
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins. It also provides E-xtra design engineering systems for the treatment of aortic vascular diseases.

Recent news